Copyright
©2013 Baishideng. All rights reserved.
Hepatitis C virus resistance to new specifically-targeted antiviral therapy: A public health perspective
Karina Salvatierra, Sabrina Fareleski, F Xavier López-Labrador, Joint Unit in Genomics and Health, Centre for Public Health Research, Public Health Department, Generalitat Valenciana/Institut Cavanilles, University of Valencia, 46020 Valencia, Spain
Alicia Forcada, Instituto de Biomedicina de Valencia-Consejo Superior de Investigaciones Científicas, 46010 Valencia, Spain
F Xavier López-Labrador, CIBER in Epidemiology and Public Health (CIBER-ESP), Instituto de Salud Carlos III, 46020 Valencia, Spain
F Xavier López-Labrador, Department of Microbiology, Medical School, University of Valencia, 46010 Valencia, Spain
Author contributions: Salvatierra K and Fareleski S contributed equally to this work; all authors wrote the review article.
Supported by The Fondo de Investigación Sanitaria, Instituto de Salud Carlos III, Spanish Ministry of Economy, Directorate of Science (PI10/00512 and CIBER-ESP); López-Labrador FX Holds a P.I. Position supported by the Fondo de Investigación Sanitaria, Instituto de Salud Carlos III, Spain
Correspondence to: Dr. F Xavier López-Labrador, Joint Unit in Genomics and Health, Centre for Public Health Research, Public Health Department, Generalitat Valenciana/Institut Cavanilles, University of Valencia, Av. Catalunya 21, 46020 Valencia, Spain. f.xavier.lopez@uv.es
Telephone: +34-96-1985839 Fax: +34-96-1925703
Received: April 7, 2012
Revised: December 30, 2012
Accepted: January 17, 2013
Published online: February 12, 2013
Revised: December 30, 2012
Accepted: January 17, 2013
Published online: February 12, 2013
Core Tip